Markets
4.4
Wall Street biotech investor angst deepens beneath surface
Published 2 d ago1 sourceEvidence: Reported
SeverityModerateSTAT NewsLow-rated sourceUS
The Brussels BEL 20 index fell after five consecutive sessions of gains, with biotech arGEN-X dropping 4.09% and Syensqo losing 2.41%. The pullback is a routine market correction following a sustained rally, with no clear macro catalyst; AB InBev and Melexis posted gains, indicating sector rotation rather than broad risk-off.
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago9 sourcesEvidence: Reported
Published 2 d ago8 sourcesEvidence: Reported
Published 2 d ago6 sourcesEvidence: Reported
Published 2 d ago5 sourcesEvidence: Reported
Published 2 d ago4 sourcesEvidence: Reported
Published 1 d ago21 sourcesEvidence: Reported